Drug category: antineoplastic drugs category: biological response regulator

Drug name: Tremella.

Drug alias: serial number Chinese alias English alias

Preparation/specification: serial number, preparation specification

1 syrup100 ml; ; 500ml (each ml contains not less than 4mg of sugar and not less than 0.6mg of glucuronic acid).

2 capsules of 0.25g; 0.5g

Composition/chemical structure: the chemical structure of the serial number composition.

Pharmacological action: It is an immune enhancer of basidiomycete polysaccharide, which can improve the immune function of the body and increase white blood cells. It can significantly improve the phagocytic function of reticuloendothelial cells in experimental animals, promote nonspecific immunity, and improve the levels of immunoglobulin and serum total complement. It can prevent and treat bone marrow suppression caused by radiation and antineoplastic drugs (such as CTX), and promote the synthesis of protein in liver.

Pharmacokinetics:

Indications: 1. Leukopenia caused by radiotherapy and chemotherapy.

2. Chronic tracheitis.

Administration and dosage: oral: each time 1g, 2 ~ 3 times a day. The treatment of leukopenia takes 14 days as a course of treatment. If the hemogram does not recover, stop taking the medicine and switch to other treatments. Immunotherapy 1 ~ 2 months is a course of treatment.

Adverse reactions: No adverse reactions were found in clinic.

Interaction:

Note: Store in a closed and cool place.

Efficacy evaluation: It can improve the immune function of patients with leukopenia caused by radiotherapy and chemotherapy. Treating chronic bronchitis, the effective rate is over 80%.